Discussion
Papers
The Incentives for Global Health Discussion Paper series provides informed commentary about how the Health Impact Fund can be developed. We hope they also stimulate conversation and debate on the Health Impact Fund and related topics. The papers in the series will offer a variety of views, many of which may be challenging.
Readers are encouraged to submit comments to the papers' authors.
Scholars interested in inclusion in the series are welcome to contact
us at igh@yale.edu.
Thomas Pogge, "The Health Impact Fund: More justice and efficiency in global health," Crawford School of Economic and Government, Australian National University, Discussion Paper 7, August 2011.
Discussion Paper Number 9. Aidan Hollis and Thomas Pogge, "Product-
Development Partnerships and the Health Impact Fund."
Discussion Paper Number 8. Joy Mendel and Aidan Hollis, "The Health Impact Fund and Traditional Medicines."
Discussion Paper Number 7. Peter Singer and Doris Schroeder, lead authors, "Ethical Reasons for Intellectual Property Rights Reform: A Report (D1.3) for Innova-P2."
Discussion Paper Number 6. Rudolf V. Van Puymbroeck, "The Health Impact Fund: Creation and Commitment."
Discussion Paper Number 5. Juggs Ravalia and Lennart Stern, "The MHIF System: Supporting the Health Impact Fund with Mobile Technology."
Discussion Paper Number 4. Kalipso Chalkidou, "Assessing the Added Value of Health Technologies: NICE’s Experience in England"
Discussion Paper Number 3. Thomas J. Bollyky, "The Relationship of
the Health Impact Fund and Its Registrants"
Discussion Paper Number 2. Talha Syed, "Should a Prize System
for Pharmaceuticals Require Patent Protection for Eligibility?"
Discussion Paper Number 1. Aidan Hollis, "The Health Impact Fund and Price Determination"
